BMI View: A new wave of drug price cuts in Morocco and the implementation of the final stage of its
universal healthcare coverage programme will see an improvement in the population’s access to medicines.
While increasing access to medicines is positive for drugmakers, we highlight that the Moroccan
pharmaceutical market will become increasingly challenging for innovative drugmakers due to the lack of
clarity regarding further medicine price cuts and the increasing market share of generic medicines.
Headline Expenditure Projections
? Pharmaceuticals: MAD10.63bn (USD1.13bn) in 2014 to MAD11.33bn (USD1.21bn) in 2015; +6.6% in
local currency terms and +7.4% in US dollar terms.
? Healthcare: MAD62.77bn (USD6.67bn) in 2014 to MAD67.97bn (USD7.28bn) in 2015; +8.3% in local
currency terms and +9.1% in US dollar terms.

Table of Contents

BMI Industry View 7
SWOT 9
Political 11
Economic 13
Operational Risk 15
Industry Forecast 17
Pharmaceutical Market Forecast 17
Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2011-2019) 19
Healthcare Market Forecast 19
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 21
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019) 22
Prescription Drug Market Forecast 22
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 24
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 26
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 29
OTC Medicine Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2011-2019) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2013-2019) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2013-2019) 34
Key Risks To BMI's Forecast Scenario 35
Macroeconomic Forecasts 36
Economic Analysis 36
Table: BMI Crude Oil Price Forecasts 39
Table: Various Countries - Real GDP Growth, % 43
Industry Risk Reward Ratings 44
Middle East And Africa Risk/Reward Index 44
Morocco Risk/ Reward Index 52
Rewards 52
Risks 53
Market Overview 55
Industry Trends And Developments 56
Epidemiology 56
Healthcare Sector 58
Table: Healthcare Resources (2009-2014) 62
Table: Healthcare Activity (2009-2014) 63
Table: Healthcare Personnel (2009-2014) 63
Healthcare Insurance 63
Recent Health Insurance Developments 65
Research & Development 68
Clinical Trials 69
Regulatory Development 70
Intellectual Property Regime 71
Pricing Regime 71
Reimbursement Regime 74
Competitive Landscape 76
Pharmaceutical Industry 76
Table: Morocco's Select Pharmaceutical Industry Indicators 76
Table: Members Of MIS, 2011 77
Table: Members Of AMIP, 2011 78
Domestic Pharmaceutical sector 78
Foreign Pharmaceutical Companies 79
Pharmaceutical Wholesale 81
Pharmaceutical Retail 82
Company Profile 84
Sothema 84
Laprophan 87
Promopharm 90
Sanofi 92
Pfizer 96
GlaxoSmithKline 99
Ranbaxy 101
Demographic Forecast 103
Demographic Outlook 103
Table: Population Headline Indicators (Morocco 1990-2025) 104
Table: Key Population Ratios (Morocco 1990-2025) 104
Table: Urban/Rural Population & Life Expectancy (Morocco 1990-2025) 105
Table: Population By Age Group (Morocco 1990-2025) 105
Table: Population By Age Group % (Morocco 1990-2025) 106
Glossary 108
Methodology 110
Pharmaceutical Expenditure Forecast Model 110
Healthcare Expenditure Forecast Model 110
Notes On Methodology 111
Risk/Reward Index Methodology 112
Index Overview 113
Table: Pharmaceutical Risk/Reward Index Indicators 113
Indicator Weightings 114

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Morocco 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Morocco 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Morocco 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (Morocco 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Morocco 2013-2019)
Table: BMI Crude Oil Price Forecasts
Table: Various Countries - Real GDP Growth,
%Table: Healthcare Resources (2009-2014)
Table: Healthcare Activity (2009-2014)
Table: Healthcare Personnel (2009-2014)
Table: Morocco's Select Pharmaceutical Industry Indicators
Table: Members Of MIS, 2011
Table: Members Of AMIP, 2011
Table: Population Headline Indicators (Morocco 1990-2025)
Table: Key Population Ratios (Morocco 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Morocco 1990-2025)
Table: Population By Age Group (Morocco 1990-2025)
Table: Population By Age Group % (Morocco 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators